Individuals carrying germline mutations in one allele of the BRCA1 or BRCA2 genes are at significantly increased risk of...
...BRCA1 and BRCA2, to a multicapillary DNA sequencer in order to increase the throughput of this technique. This new metho...
...BRCA1 and BRCA2, we are identifying more and more women who have an 80% or more lifetime risk of developing breast cance...
BRCA1-related breast cancer frequently has a basal epithelial phenotype, and P-cadherin is a basal marker. We undertook ...
...BRCA1 and BRCA2 genes. A joint analysis of the Polish and the German study population revealed a 54% increased risk for ...
...BRCA1, BRCA2, or TP53 mutation. We recruited participants from 22 centres in the UK, and offered the women annual screen...
...BRCA1 and BRCA2 mutation testing is necessary for effective utilization of testing in the community. Education and couns...
Mutations in the known predisposing breast cancer genes BRCA1 and BRCA2 account for only a small proportion (<10%) of br...
...BRCA1 or BRCA2 mutations. Medical records were reviewed to document the characteristics of each cancer and the treatment...
...BRCA1/2. Different approaches to risk communication need to be developed and evaluated in parallel with communications s...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
